Literature DB >> 18979631

Metastasis-associated C4.4A, a GPI-anchored protein cleaved by ADAM10 and ADAM17.

Cary W Esselens1, Jordi Malapeira, Núria Colomé, Marcia Moss, Francesc Canals, Joaquín Arribas.   

Abstract

Metalloproteases play a complex role in tumor progression. While the activity of some ADAM, ADAMTS and matrix metalloproteases (MMPs) seems to be protumorigenic, the activity of others seems to prevent tumor progression. The identification of the array of substrates of a given metalloprotease (degradome) seems an adequate approach to predict the effect of the inhibition of a metalloprotease in tumors. Here, we present the proteomic identification of a novel substrate for ADAM10 and -17. We used SILAC (Stable Isotope Labeling by Amino acids in Cell culture), a proteomic technique based on the differential metabolic labeling of cells in different conditions. This was applied to MCF7 cells derived from an invasive mammary tumor, and the same cells expressing shRNAs that knock down ADAM10 or -17. Following this approach, we have identified C4.4A as a substrate to both metalloproteases. Since C4.4A is likely involved in tumor invasion, these results indicate that the cleavage of C4.4A by ADAM10 and ADAM17 contributes to tumor progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18979631     DOI: 10.1515/bc.2008.121

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  11 in total

1.  Membrane-bound and exosomal metastasis-associated C4.4A promotes migration by associating with the α(6)β(4) integrin and MT1-MMP.

Authors:  Honoré Ngora; Uwe M Galli; Kaoru Miyazaki; Margot Zöller
Journal:  Neoplasia       Date:  2012-02       Impact factor: 5.715

Review 2.  Regulation of cell signalling by uPAR.

Authors:  Harvey W Smith; Chris J Marshall
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

3.  Cytotoxic activity of immunotoxin SS1P is modulated by TACE-dependent mesothelin shedding.

Authors:  Yujian Zhang; Oleg Chertov; Jingli Zhang; Raffit Hassan; Ira Pastan
Journal:  Cancer Res       Date:  2011-07-20       Impact factor: 12.701

4.  Tumorigenicity of cortical astrocyte cell line induced by the protease ADAM17.

Authors:  Mark Katakowski; Feng Jiang; XuGuang Zheng; Jorge A Gutierrez; Alexandra Szalad; Michael Chopp
Journal:  Cancer Sci       Date:  2009-05-18       Impact factor: 6.716

5.  The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration.

Authors:  Cary Esselens; Jordi Malapeira; Núria Colomé; Carmen Casal; Juan Carlos Rodríguez-Manzaneque; Francesc Canals; Joaquín Arribas
Journal:  J Biol Chem       Date:  2009-11-13       Impact factor: 5.157

Review 6.  Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review.

Authors:  Emily Dexter; Qingzhong Kong
Journal:  Expert Rev Neurother       Date:  2021-09-02       Impact factor: 4.287

Review 7.  Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms.

Authors:  Kristina Endres; Thomas Deller
Journal:  Front Mol Neurosci       Date:  2017-03-17       Impact factor: 5.639

Review 8.  SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.

Authors:  Wei-Sheng Tien; Jun-Hong Chen; Kun-Pin Wu
Journal:  BMC Bioinformatics       Date:  2017-03-14       Impact factor: 3.169

9.  A proteomic analysis of the statocyst endolymph in common cuttlefish (Sepia officinalis): an assessment of acoustic trauma after exposure to sound.

Authors:  M Solé; M Monge; M André; C Quero
Journal:  Sci Rep       Date:  2019-06-27       Impact factor: 4.379

10.  Analysis of mutations in primary and metastatic synovial sarcoma.

Authors:  Zhuo Xing; Lei Wei; Xiaoling Jiang; Jeffrey Conroy; Sean Glenn; Wiam Bshara; Tao Yu; Annie Pao; Shinya Tanaka; Akira Kawai; Christopher Choi; Jianmin Wang; Song Liu; Carl Morrison; Y Eugene Yu
Journal:  Oncotarget       Date:  2018-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.